Skip to main content
Ind-Swift Laboratories Ltd. logo

Ind-Swift Laboratories Ltd. — Investor Relations & Filings

Ticker · INDSWFTLAB ISIN · INE915B01019 LEI · 335800ZT8UFD9Y8ZMP56 BSE.NS Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2025-05-30 Regulatory Filings
Country IN India
Listing BSE.NS INDSWFTLAB

About Ind-Swift Laboratories Ltd.

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd. is a global manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. The company focuses on research and development, process chemistry, and large-scale production across diverse therapeutic segments, including macrolide antibiotics, cardiovascular agents, antihistamines, antidiabetics, and antipsychotics. Operating multiple manufacturing facilities that adhere to international regulatory standards such as USFDA, EDQM, and PMDA, the organization provides high-quality chemical entities to the global market. Its core competencies lie in complex chemical synthesis and the development of cost-effective manufacturing processes for generic and specialty drug substances. The company maintains a strong emphasis on quality assurance and regulatory compliance to support its extensive portfolio of products distributed worldwide.

Recent filings

Filing Released Lang Actions
Resignation of Independent director
Regulatory Filings
2025-05-30 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a Board Meeting held on May 30, 2025. It includes disclosures pursuant to SEBI regulations, specifically Regulation 30 and 33 of SEBI (LODR) Regulations, 2015. The key points are: 1) The Board decided not to adopt pre-merger audited financial statements for FY 2024-25 due to an ongoing merger, indicating a delay in financial results submission. 2) Resignation of a Non-executive Independent Director with details attached as annexures. 3) Reconstitution of Board Committees. The document is primarily an announcement of board decisions and regulatory disclosures rather than a full financial report or detailed management discussion. It does not contain actual financial statements or detailed financial analysis. The presence of resignation details and committee reconstitution points to Board/Management Information. Therefore, the document fits best under the category of Board/Management Information (MANG).
2025-05-30 English
Amalgamation/Merger
Legal Proceedings Report Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding an update on a legal proceeding related to the approval of a Scheme of Arrangement for amalgamation between two companies. It references a hearing date set by the National Company Law Tribunal (NCLT). The document is short (1436 characters) and serves as an announcement of a legal proceeding update rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed legal analysis, but rather a regulatory disclosure under listing obligations. This fits best under Legal Proceedings Report (LTR) as it updates on a significant legal matter involving the company.
2025-05-29 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-23 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of a Board meeting scheduled to consider and approve the audited financial results for the quarter and financial year ended March 31, 2025. It is a formal announcement pursuant to SEBI Listing Regulations about the upcoming board meeting date and related procedural information. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a short notice informing the stock exchanges and public about the meeting and the agenda. Therefore, it is an announcement related to a report rather than the report itself. Given the short length (1807 characters) and the nature of the content, this fits the criteria for a Regulatory Filing (RNS) as a general regulatory announcement rather than a full financial report or other specific category.
2025-05-23 English
Updates
Legal Proceedings Report Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, addressed to stock exchanges. It provides an update on ongoing arbitration proceedings, including procedural details such as the reconstitution of the arbitral tribunal and the timetable for completion of proceedings. The document is a regulatory announcement informing stakeholders about legal proceedings but does not contain financial statements, audit results, or detailed management discussion. It is not a full report but a regulatory update related to legal matters. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is short and it is not a report publication announcement or certification. Hence, the classification is LTR with high confidence.
2025-05-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.